Optimization of proteomic sample preparation procedures for comprehensive protein characterization of pathogenic systems

Journal of Biomolecular Techniques

Volumn 19, Issue 5, 2008, Pages 285-295

  Mottaz Brewer, Heather M ^a   Norbeck, Angela D ^a   Adkins, Joshua N ^a   Manes, Nathan P ^a   Ansong, Charles ^a   Shi, Liang ^a   Rikihisa, Yasuko ^b   Kikuchi, Takane ^b   Wong, Scott W ^c   Estep, Ryan D ^c   Heffron, Fred ^c   Pasa Tolic, Ljiljana ^a   Smith, Richard D ^a  

^a PACIFIC NORTHWEST NATIONAL LABORATORY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Mass spectrometry; Methods; Pathogens; Proteomics; Sample preparation

Indexed keywords

PROTEOME;

ANAPLASMA PHAGOCYTOPHILUM; ANIMAL; ARTICLE; BIOTECHNOLOGY; CHEMISTRY; EHRLICHIA CHAFFEENSIS; HELA CELL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HOST PATHOGEN INTERACTION; HUMAN; ISOLATION AND PURIFICATION; MASS SPECTROMETRY; METHODOLOGY; MONKEYPOX VIRUS; PATHOGENICITY; PHYSIOLOGY; PROTEOMICS; SALMONELLA; SENSITIVITY AND SPECIFICITY; STATISTICS; SYSTEMS BIOLOGY; TANDEM MASS SPECTROMETRY; VACCINIA VIRUS;

ANAPLASMA PHAGOCYTOPHILUM; ANIMALS; BIOTECHNOLOGY; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; EHRLICHIA CHAFFEENSIS; HELA CELLS; HOST-PATHOGEN INTERACTIONS; HUMANS; MASS SPECTROMETRY; MONKEYPOX VIRUS; PROTEOME; PROTEOMICS; SALMONELLA; SENSITIVITY AND SPECIFICITY; SYSTEMS BIOLOGY; TANDEM MASS SPECTROMETRY; VACCINIA VIRUS;

EID: 63449105999     PISSN: 15240215     EISSN: 19434731     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Manes NP, Estep RD, Mottaz HM, et al. Comparative proteomics of human monkeypox and vaccinia intracellular mature and extracellular enveloped virions. J Proteome Res 2008;7(3):960-968.
2. Dawson JE, Anderson BE, Fishbein DB, et al. Isolation and characterization of an Ehrlichia sp. from a patient diagnosed with human ehrlichiosis. J Clin Microbiol 1991;29(12):2741-2745.
3. Rikihisa Y, Zhi N, Wormser GP, et al. Ultrastructural and antigenic characterization of a granulocytic ehrlichiosis agent directly isolated and stably cultivated from a patient in New York state. J Infect Dis 1997;175(1):210-213.
4. Mott J, Barnewall RE, Rikihisa Y. Human granulocytic ehrlichiosis agent and Ehrlichia chaffeensis reside in different cytoplasmic compartments in HL-60 cells. Infect Immun 1999;67(3):1368-1378.
5. Shi L, Adkins JN, Coleman JR, et al. Proteomic analysis of Salmonella enterica serovar typhimurium isolated from RAW 264.7 macrophages: identification of a novel protein that contributes to the replication of serovar typhimurium inside macrophages. J Biol Chem 2006;281(39):29131-29140.
6. Ansong C YH, Norbeck AD, Gustin JK, et al. Proteomics analysis of the causative agent of typhoid fever. J Proteome Res 2008;7(2):546-557.
7. Adkins JN, Mottaz HM, Norbeck AD, et al. Analysis of the Salmonella typhimurium proteome through environmental response toward infectious conditions. Mol Cell Proteomics 2006;5(8):1450-1461.
8. Eng JK, McCormack AL, Yates JR. An approach to correlate tandem mass-spectral data of peptides with amino-acid-sequences in a protein database. J Am Soc Mass Spect 1994;5(11):976-989.
9. Keller A, Nesvizhskii AI, Kolker E, Aebersold R. Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search. Anal Chem 2002;74(20):5383-5392.
10. Washburn MP, Wolters D, Yates JR, 3rd. Large-scale analysis of the yeast proteome by multidimensional protein identification technology. Nat Biotechnol 2001;19(3):242-247.
11. Blonder J, Hale ML, Lucas DA, et al. Proteomic analysis of detergent-resistant membrane rafts. Electrophoresis 2004;25(9):1307-1318.
12. Umar A, Luider TM, Foekens JA, Pasa-Tolic L. NanoLC-FTICR MS improves proteome coverage attainable for approximately 3000 laser-microdissected breast carcinoma cells. Proteomics 2007;7(2):323-329.
13. Diamond DL, Jacobs JM, Paeper B, et al. Proteomic profiling of human liver biopsies: hepatitis C virus-induced fibrosis and mitochondrial dysfunction. Hepatology 2007;46(3):649-657.
14. Rosenfeld J, Capdevielle J, Guillemot JC, Ferrara P. In-gel digestion of proteins for internal sequence analysis after one- or twodimensional gel electrophoresis. Anal Biochem 1992;203(1):173-179.
15. Han MJ, Speicher DW. Microscale Isoelectric Focusing in Solution: A Method for Comprehensive and Quantitative Proteome Analysis Using 1-D and 2-D DIGE Combined with MicroSol IEF Prefractionation. Methods Mol Biol 2008;424:241-256.
16. Callewaert L, Aertsen A, Deckers D, et al. A new family of lysozyme inhibitors contributing to lysozyme tolerance in gramnegative bacteria. PLoS Pathog 2008;4(3):e1000019.
17. Patel JC, Galan JE. Investigating the function of rho family GTPases during Salmonella/host cell interactions. Methods Enzymol 2008;439:145-158.
18. Beuzon CR, Meresse S, Unsworth KE, et al. Salmonella maintains the integrity of its intracellular vacuole through the action of SifA. Embo J 2000;19(13):3235-3249.
19. Hixson KK, Adkins JN, Baker SE, et al. Biomarker candidate identification in Yersinia pestis using organism-wide semiquantitative proteomics. J Proteome Res 2006;5(11):3008-3017.
20. Hmiel SP, Snavely MD, Miller CG, Maguire ME. Magnesium transport in Salmonella typhimurium: characterization of magnesium influx and cloning of a transport gene. J Bacteriol 1986;168(3):1444-1450.
21. Resch W, Hixson KK, Moore RJ, Lipton MS, Moss B. Protein composition of the vaccinia virus mature virion. Virology 2007;358(1):233-247.
22. Diamond DL, Proll SC, Jacobs JM, et al. HepatoProteomics: applying proteomic technologies to the study of liver function and disease. Hepatology 2006;44(2):299-308.
23. Jacobs JM, Diamond DL, Chan EY, et al. Proteome analysis of liver cells expressing a full-length hepatitis C virus (HCV) replicon and biopsy specimens of posttransplantation liver from HCV-infected patients. J Virol 2005;79(12):7558-7569.
24. Chen EI, Hewel J, Felding-Habermann B, Yates JR, 3rd. Large scale protein profiling by combination of protein fractionation and multidimensional protein identification technology (Mud-PIT). Mol Cell Proteomics 2006;5(1):53-56.
25. Liu T, Qian WJ, Strittmatter EF, et al. High-throughput comparative proteome analysis using a quantitative cysteinyl-peptide enrichment technology. Anal Chem 2004;76(18):5345-5353.
26. Fried M, Wendler JP, Mutabingwa TK, Duffy PE. Mass spectrometric analysis of Plasmodium falciparum erythrocyte membrane protein-1 variants expressed by placental malaria parasites. Proteomics 2004;4(4):1086-1093.
27. Fried M, Hixson KK, Anderson L, et al. The distinct proteome of placental malaria parasites. Mol Biochem Parasitol 2007;155(1):57-65.
28. Varnum SM, Streblow DN, Monroe ME, et al. Identification of proteins in human cytomegalovirus (HCMV) particles: the HCMV proteome. J Virol 2004;78(20):10960-10966.
29. Stromhaug PE, Berg TO, Fengsrud M, Seglen PO. Purification and characterization of autophagosomes from rat hepatocytes. Biochem J 1998;335 (Pt 2):217-224.
30. Zhou W, Merrick BA, Khaledi MG, Tomer KB. Detection and sequencing of phosphopeptides affinity bound to immobilized metal ion beads by matrix-assisted laser desorption/ionization mass spectrometry. J Am Soc Mass Spectrom 2000;11(4):273-282.
31. Smith RD, Anderson GA, Lipton MS, et al. An accurate mass tag strategy for quantitative and high-throughput proteome measurements. Proteomics 2002;2(5):513-523.
32. Monroe ME, Tolic N, Jaitly N, et al. VIPER: an advanced software package to support high-throughput LC-MS peptide identification. Bioinformatics 2007;23(15):2021-2023.
33. Zimmer JS, Monroe ME, Qian WJ, Smith RD. Advances in proteomics data analysis and display using an accurate mass and time tag approach. Mass Spectrom Rev 2006;25(3):450-482.
34. Livesay EA, Tang K, Taylor BK, et al. Fully automated fourcolumn capillary LC-MS system for maximizing throughput in proteomic analyses. Anal Chem 2008;80(1):294-302.
35. Craig R, Beavis RC. TANDEM: matching proteins with tandem mass spectra. Bioinformatics 2004;20(9):1466-1467.
36. Kapp EA, Schutz F, Connolly LM, et al. An evaluation, comparison, and accurate benchmarking of several publicly available MS/MS search algorithms: sensitivity and specificity analysis. Proteomics 2005;5(13):3475-3490.
37. Ansong C, Purvine SO, Adkins JN, Lipton MS, Smith RD. Proteogenomics: needs and roles to be filled by proteomics in genome annotation. Brief Funct Genomic Proteomic 2008;7(1):50-62.
38. Moore RE, Young MK, Lee TD. Qscore: an algorithm for evaluating SEQUEST database search results. J Am Soc Mass Spectrom 2002;13(4):378-386.
39. Peng J, Elias JE, Thoreen CC, Licklider LJ, Gygi SP. Evaluation of multidimensional chromatography coupled with tandem mass spectrometry (LC/LC-MS/MS) for large-scale protein analysis: the yeast proteome. J Proteome Res 2003;2(1):43-50.
40. Qian WJ, Liu T, Monroe ME, et al. Probability-based evaluation of peptide and protein identifications from tandem mass spectrometry and SEQUEST analysis: the human proteome. J Proteome Res 2005;4(1):53-62.
41. Xue X, Wu S, Wang Z, Zhu Y, He F. Protein probabilities in shotgun proteomics: evaluating different estimation methods using a semi-random sampling model. Proteomics 2006;6(23):6134-6145.
42. Nesvizhskii AI, Keller A, Kolker E, Aebersold R. A statistical model for identifying proteins by tandem mass spectrometry. Anal Chem 2003;75(17):4646-4658.
43. Bartee E, McCormack A, Fruh K. Quantitative membrane proteomics reveals new cellular targets of viral immune modulators. PLoS Pathog 2006;2(10):e107.
44. Jacobs JM, Yang X, Luft BJ, et al. Proteomic analysis of Lyme disease: global protein comparison of three strains of Borrelia burgdorferi. Proteomics 2005;5(5):1446-1453.
45. Khan AS, Mujer CV, Alefantis TG, et al. Proteomics and bioinformatics strategies to design countermeasures against infectious threat agents. J Chem Inf Model 2006;46(1):111-115.
46. Kuijl C, Savage ND, Marsman M, et al. Intracellular bacterial growth is controlled by a kinase network around PKB/AKT1. Nature 2007;450(7170):725-730.
47. Klade CS. Proteomics approaches towards antigen discovery and vaccine development. Curr Opin Mol Ther 2002;4(3):216-223.
48. Chakravarti DN, Fiske MJ, Fletcher LD, Zagursky RJ. Application of genomics and proteomics for identification of bacterial gene products as potential vaccine candidates. Vaccine 2000;19(6):601-612.
49. Morsczeck C, Prokohova T, Sigh J, et al. Streptococcus pneumoniae: proteomics of surface proteins for vaccine development. Clin Microbiol Infect 2008;14(1):74-81.
50. Kaushik DK, Sehgal D. Developing antibacterial vaccines in genomics and proteomics era. Scand J Immunol 2008.